ArticleCancer gene therapy2026

Ataxia-telangiectasia mutated kinase inhibition overcomes gemcitabine resistance in intrahepatic cholangiocarcinoma via DNA ligase I-dependent repair vulnerability.

Sheng-Hsuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.